Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications

Expert Review of Anticancer Therapy
Irene Panagiotou, Kyriaki Mystakidou

Abstract

Fentanyl, a short-acting synthetic pure opiate, offers an excellent option for the treatment of cancer and chronic pain. While oral administration is not an option, its high potency and lipophilicity have made intranasal administration feasible. Intranasal fentanyl has a bioavailability of 89%, with a short onset of action ( approximately 7 min) and duration times ( approximately 1 h). It bypasses the oral/gastrointestinal route, delivers the analgesic dose in a volume of 150 microl that can be adequately absorbed and, with a pH of 6.4, avoids local irritation. Intranasal fentanyl has been investigated to assess its potential as a well-tolerated acute postoperative breakthrough pain relief medication. It has been shown to be superior to oral transmucosal fentanyl for the treatment of cancer breakthrough pain. Similar analgesic effects to fentanyl or morphine intravenously and orally, with a similar safety profile, have been reported for postoperative or acute pain treatment of children and adults in the prehospital and hospital settings.

References

Jan 8, 1999·Journal of Pain and Symptom Management·S L CollinsH J McQuay
Feb 11, 2000·Clinical Pharmacokinetics·S GrondK A Lehmann
Apr 14, 2000·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·S ToussaintH W Striebel
Mar 10, 2001·British Journal of Cancer·G W HanksUNKNOWN Expert Working Group of the Research Network of the European Association for Palliative Care
Sep 29, 2001·Anesthesiology·W Ueda
Feb 2, 2002·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Ray ManjushreeKrishna Handa
Feb 22, 2002·Cancer·Sebastiano MercadanteUNKNOWN Steering Committee of the European Association for Palliative Care (EAPC) Research Network
Jul 26, 2002·Acta Anaesthesiologica Scandinavica·O DaleE D Kharasch
Apr 15, 2004·Burns : Journal of the International Society for Burn Injuries·Judith FinnAnna Gelavis
Jul 14, 2004·Advances in Psychosomatic Medicine·Paul J ChristoSrinivasa N Raja
Mar 2, 2005·European Journal of Pain : EJP·Kristina B SvendsenTroels S Jensen
Dec 27, 2005·Journal of Pain and Symptom Management·Andrew N Davies, Joanna Vriens
Jun 13, 2006·Drug Delivery·Kyriaki MystakidouMarinos L Tsiatas
Aug 4, 2006·The Journal of Pain : Official Journal of the American Pain Society·Russell K PortenoySteven Shoemaker
Oct 9, 2007·The American Journal of Emergency Medicine·Claire RickardPeter Le Lievre
Jan 9, 2008·European Journal of Clinical Pharmacology·Kristin MoksnesOla Dale
Feb 28, 2008·Drugs of Today·John MessinaPerry G Fine
Jun 1, 1993·Der Schmerz·H W StriebelA Rieger
Jan 8, 2009·Emergency Medicine Australasia : EMA·Meredith Louise BorlandAmanda Esson

❮ Previous
Next ❯

Citations

Oct 27, 2012·Clinical Pharmacokinetics·Jörn LötschGerd Geisslinger
May 17, 2011·Patient Preference and Adherence·Eric Prommer, Lisa Thompson
Feb 18, 2012·Future Oncology·Donald R Taylor, Nash Gabrail
Feb 10, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Mert KüçükMustafa Oğurlu
Jan 21, 2012·Acta Anaesthesiologica Scandinavica·M S HansenJ B Dahl
Nov 26, 2013·Annals of Emergency Medicine·Anders P KarlsenMorten S Hansen
Oct 30, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sebastiano MercadanteAlessandra Casuccio
Jul 6, 2016·Frontiers in Aging Neuroscience·Milica ProstranNataša Cerovac
Nov 9, 2016·Annals of Emergency Medicine·Daniel S TszePeter S Dayan
Oct 11, 2014·The Cochrane Database of Systematic Reviews·Adrian MurphyNandini Kandamany
May 28, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Brigitte GeorgeAntoine Lemaire
Jan 24, 2020·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Alain TanguayFrançois Bégin
Aug 11, 2020·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Jason McMullanChristopher Lindsell
Nov 15, 2012·Current Opinion in Supportive and Palliative Care·Romayne Gallagher
Mar 25, 2017·Drugs·Stephan A Schug, Sonya Ting
Sep 11, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Pooja Shah, Anita Siu
Feb 6, 2021·Pharmaceutics·Anna FroelichBozena Michniak-Kohn
Feb 16, 2011·Current Opinion in Supportive and Palliative Care

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.